Macquarie Group LTD Axonics, Inc. Transaction History

Macquarie Group LTD

$87.4 Billion
Q1 2024

A detailed history of Macquarie Group LTD transactions in Axonics, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 39,636 shares of AXNX stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,636

Previous 582,961 93.2%

Holding current value

$2.69 Million

Previous $36.3 Million 92.47%

% of portfolio

0.0%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$56.67 - $69.36 $30.8 Million - $37.7 Million	-543,325 Reduced 93.2%	39,636 $2.73 Million
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $3.21 Million - $4.15 Million	65,085 Added 12.57%	582,961 $36.3 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $4.32 Million - $5.56 Million	88,914 Added 20.73%	517,876 $29.1 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $3.26 Million - $4.09 Million	68,001 Added 18.84%	428,962 $21.6 Million
Q1 2023 May 15, 2023	SELL	$52.6 - $67.34 $5.1 Million - $6.53 Million	-97,041 Reduced 21.19%	360,961 $19.7 Million

Q4 2022 Feb 21, 2023	SELL	$59.56 - $76.6 $11 Million - $14.2 Million	-185,075 Reduced 28.78%	458,002 $28.6 Million
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $20.5 Million - $27.6 Million	-353,236 Reduced 35.45%	643,077 $45.3 Million
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $209,666 - $341,941	5,308 Added 0.54%	996,313 $56.5 Million
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $1.4 Million - $2 Million	-31,909 Reduced 3.12%	991,005 $62 Million
Q4 2021 Feb 11, 2022	SELL	$50.01 - $73.35 $6.57 Million - $9.64 Million	-131,397 Reduced 11.38%	1,022,914 $57.3 Million
Q3 2021 Nov 12, 2021	SELL	$59.21 - $78.66 $6.42 Million - $8.53 Million	-108,487 Reduced 8.59%	1,154,311 $75.1 Million
Q2 2021 Aug 13, 2021	BUY	$51.39 - $66.9 $54.5 Million - $70.9 Million	1,060,016 Added 522.74%	1,262,798 $80.1 Million
Q1 2021 May 14, 2021	BUY	$49.14 - $59.89 $1.48 Million - $1.81 Million	30,162 Added 17.47%	202,782 $12.1 Million
Q4 2020 Feb 16, 2021	BUY	$42.19 - $51.5 $2.98 Million - $3.63 Million	70,580 Added 69.17%	172,620 $8.62 Million
Q3 2020 Nov 13, 2020	BUY	$35.33 - $51.04 $1.29 Million - $1.87 Million	36,540 Added 55.79%	102,040 $5.21 Million
Q2 2020 Aug 11, 2020	BUY	$22.91 - $39.83 $77,183 - $134,187	3,369 Added 5.42%	65,500 $2.3 Million
Q1 2020 May 15, 2020	SELL	$16.44 - $37.73 $16,111 - $36,975	-980 Reduced 1.55%	62,131 $1.58 Million
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $1.24 Million - $1.83 Million	63,111 New	63,111 $1.75 Million

Others Institutions Holding AXNX

# of Institutions

241

Shares Held

41.8M

Call Options Held

213K

Put Options Held

362K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.33B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Axonics, Inc. Transaction History